Science
Pipeline
Advancing transformative medicines using Apertura’s TfR1 capsids for neurological diseases
In addition to advancing our own programs using our TfR1 capsids, we partner with organizations across the life sciences with the aim of accelerating impactful gene therapies and expanding patient access.
Drug Development Programs Utilizing TfR1 CapX
